• No se han encontrado resultados

Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha

N/A
N/A
Protected

Academic year: 2020

Share "Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha"

Copied!
7
0
0

Texto completo

Loading

Figure

Figure 1. Pre-treatment IL-6 serum levels in relation to the HBeAg

Referencias

Documento similar

Liabeuf et al., “Serum indoxyl sul- fate is associated with vascular disease and mortality in chronic kidney disease patients,” Clinical Journal of the American Society of

The main hypothesis of the SPHERE-HF ( b 3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure) trial is that maintenance treatment with

Los motivos para no recibir el tratamiento de la hepatitis C en personas con historia de abuso de sustancias son muy diversos y se des- criben en esta revisión, pero uno de los

En el caso de pacientes naïve y recidivantes sin cirrosis y ARN-VHC indetectable en la semana cuatro y doce de tratamiento, PEG-IFN y RBV podrán ser suspendidos en la semana

However, HPV types for each patient belonged to the same genus (alpha), except for one of the patients, who presented several warts from two different genera (alpha and mu) (Fig.

The objective of this project is to find out if the treatment of chronic pain with virtual reality and augmented reality obtains significantly positive results in the

1) IC/TLC, a marker of ventilator constraint due to static lung hyperinflation, is an independent determinant of exercise capacity decline in patients with COPD. 2)

Changes in serum IL-15 levels at 4 and 8 weeks as compared with baseline values were directly associated with changes in body weight, BMI, fat-free mass, and muscle mass